Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1316301

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1316301

Global Sports Medicine Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The global sports medicine market reached US$ 7.0 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.3 billion by 2030. The global sports medicine market is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).

The increase in the number of sports injuries, rising product launches, introductions of new therapies, advancements in regenerative medicine, and increasing requirements for minimally invasive surgery are among the factors expected to boost the global sports medicine market growth in the forecast period.

Market Dynamics

Increasing Market Developments Drive The Growth of the Sports Medicine Market

The increasing market developments are estimated to boost the global sports medicine market growth in the forecast period. For instnace, in March 2023, Smith+Nephew, medical technology corporation, launched the UltraTRAC QUAD ACL Reconstruction Technique comprising of the new QUADTRAC Quadriceps Tendon Harvest Guide System, X-WING Graft Preparation System and family of ULTRABUTTON Adjustable Fixation Devices.

Likewise, in July 2022, Smith+Nephew, the global medical technology corpoLikewisentroduced a potent line-up featuring a few of its refined joint repair solutions and a wide collection of educational actions in the 2022 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting being held in Colorado Springs.

The Increase Advancements are Expected to Present the Global Sports Medicine Market With Growth Opportunities

The increasing advancements are presenting the global sports medicine market with lucrative growth opportunities. For instnace, in June 2023, Aspetar, Orthopaedic, and Sports Medicine Hospital introduced its Shockwave Therapy putting it at the forefront of sports medicine.

Employing this cutting-edge technology, this state-of-the-art therapy modality is altering tissue restoration and pain drop-in sports-associated injuries, making an influential impact on athletes and individuals.

The Presence of Stringent Regulatory Bodies is Estimated to Hamper the Global Sports Medicine Market During The Forecast Period

The presence of stringent regulatory bodies for the approval of newly developed drugs for sports medicine is hampering the global market growth in the forecast period. For instnace, the major regulatory bodies supervising the authorization and commercialization of sports medicine include the United States Food and Drug Administration (USFDA) and the European Medicines Agency, an agency of the European Union in charge of the evaluation and supervision of pharmaceutical products in the European Union.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is thought to hold a moderate influence on the global sports medicine market, as there is a low incidence of sports injuries and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all Products of medications. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global sports medicine market growth in the forecast period.

Segment Analysis

The global sports medicine market is segmented based on product, application, end-user, and region.

The Ankle & Foot Injuries Application is Estimated to Dominate the Global Sports Medicine Market

Owing to the increasing product introduction for the foot and ankle sports-injury applications segment into the global sports medicine market, the segment is estimated to hold a large share of the global market accounting for about 43.9%. For instance, in June 2022, Mueller Sports Medicine, an industry leader in sports medicine for the last six decades, launched its SKY Ankle Stabilizer.

As ankle sprains are the No.1 sports injury, SKY Stabilizer strives to deliver fit ankles and avert chronic ankle instability. It was developed for participants interested in vertical jumping sports such as basketball and volleyball as Mueller concentrated on simple elements of inversion sprains and biomechanics.

Geographical Analysis

Europe is Estimated to Hold 27.6% of the Market Share Owing to the Growing Cases of Chronic Conditions in this Region

Owing to the increasing incidences of sports injury in this region the European sports medicine market is estimated to hold around 27.6% of the global market share by 2030. For instance, in September 2022, London - Howden, the international insurance vendor, reported its European Football Injury Index for the 2021/2022 season for the guys' tournament, which demonstrates that injury expenses for the mainland's leading leagues broke via the half-a-billion-pound spot for the very foremost term (£513.23m/€610.75m). The whole number of injuries sustained throughout Europe's top five clubs was around 4,810 over the course of the previous season denoting a 20% boost in the 2020/2021 season.

Competitive Landscape

The major global players in the sports medicine market include: Arthrex Inc., CONMED Corporation, Johnson & Johnson, Medtronic PLC, Mueller Sports Medicine Inc., Performance Health, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Biomet Holdings Inc. among others.

Why Purchase the Report?

  • To visualize the global sports medicine market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of sports medicine market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in Excel consisting of key products of all the major players.

The global sports medicine market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD843

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Market Developments
      • 4.1.1.2. Growing Incidences of Sports Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Authorities
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Body Reconstruction and Repair *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Body Support and Recovery
  • 7.4. Body Monitoring and Evaluation Devices
  • 7.5. Accessories

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Ankle & Foot Injuries*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Back & Spine Injuries
  • 8.4. Elbow & Wrist Injuries
  • 8.5. Hip Injuries
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Other

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Arthrex Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. CONMED Corporation
  • 12.3. Johnson & Johnson
  • 12.4. Medtronic PLC
  • 12.5. Mueller Sports Medicine Inc.
  • 12.6. Performance Health
  • 12.7. Smith & Nephew
  • 12.8. Stryker Corporation
  • 12.9. Wright Medical Group
  • 12.10. Zimmer Biomet Holdings Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!